Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls
Wissenschaftlicher Artikel
Authors
Menard, Cedric
Pacelli, Luciano
Bassi, Giulio
Dulong, Joelle
Bifari, Francesco
Institutions
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)UKU. Institut für Transfusionsmedizin
Published in
Stem Cells and Development ; 22 (2013), 12. - S. 1789-1801. - ISSN 1547-3287
Link to publication
https://dx.doi.org/10.1089/scd.2012.0594EU Project
REBORNE / Regenerating Bone defects using New biomedical Engineering approaches / EC / FP7 / 241879
Keywords
INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; ANTIINFLAMMATORY PROTEIN TSG-6; VERSUS-HOST-DISEASE; STEM-CELLS; BONE-MARROW; ADIPOSE-TISSUE; PLATELET LYSATE; T-LYMPHOCYTES; MEDIATED IMMUNOSUPPRESSION; INTERFERON-GAMMADewey Decimal Group
DDC 610 / Medicine & healthDDC 620 / Engineering & allied operations